AU2001291731A1 - Pharmaceutical, effervescent formulation containing ramipril - Google Patents

Pharmaceutical, effervescent formulation containing ramipril

Info

Publication number
AU2001291731A1
AU2001291731A1 AU2001291731A AU9173101A AU2001291731A1 AU 2001291731 A1 AU2001291731 A1 AU 2001291731A1 AU 2001291731 A AU2001291731 A AU 2001291731A AU 9173101 A AU9173101 A AU 9173101A AU 2001291731 A1 AU2001291731 A1 AU 2001291731A1
Authority
AU
Australia
Prior art keywords
pharmaceutical
effervescent formulation
formulation containing
ramipril
containing ramipril
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001291731A
Other languages
English (en)
Inventor
Brigitte Freudensprung
Alexandra Hager
Karin Klokkers
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hexal AG
Original Assignee
Hexal AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hexal AG filed Critical Hexal AG
Publication of AU2001291731A1 publication Critical patent/AU2001291731A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2001291731A 2000-08-05 2001-08-03 Pharmaceutical, effervescent formulation containing ramipril Abandoned AU2001291731A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10038364.5 2000-08-05
DE10038364A DE10038364A1 (de) 2000-08-05 2000-08-05 Pharmazeutische, Ramipril enthaltende Brauseformulierung
PCT/EP2001/008999 WO2002011709A2 (fr) 2000-08-05 2001-08-03 Formulation pharmaceutique effervescente contenant du ramipril

Publications (1)

Publication Number Publication Date
AU2001291731A1 true AU2001291731A1 (en) 2002-02-18

Family

ID=7651509

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001291731A Abandoned AU2001291731A1 (en) 2000-08-05 2001-08-03 Pharmaceutical, effervescent formulation containing ramipril

Country Status (5)

Country Link
EP (1) EP1309319B1 (fr)
AT (1) ATE291421T1 (fr)
AU (1) AU2001291731A1 (fr)
DE (2) DE10038364A1 (fr)
WO (1) WO2002011709A2 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2357982A1 (fr) * 2001-09-28 2003-03-28 Bernard Charles Sherman Compositions solides contenant du ramipril
GB2394660A (en) * 2003-12-17 2004-05-05 Niche Generics Ltd Stabilisation of pharmaceutical compositions comprising ACE inhibitor by absence of acidic excipients having large specific surface area, eg silicon dioxide
EA011862B1 (ru) 2004-03-24 2009-06-30 Актавис Груп Хф. Композиции рамиприла
US20070172524A1 (en) 2004-03-29 2007-07-26 Krka, Tovarna Zdravil, D.D., Novo Mesto Process for preparing a solid pharmaceutical composition
KR100591857B1 (ko) * 2004-06-04 2006-06-23 한국유나이티드제약 주식회사 안정성이 개선된 라미프릴 함유 약제학적 조성물
GB0518129D0 (en) * 2005-09-06 2005-10-12 Arrow Int Ltd Ramipril formulation
GB2431579A (en) * 2005-10-28 2007-05-02 Arrow Int Ltd Ramipril formulations
GB0624090D0 (en) * 2006-12-01 2007-01-10 Selamine Ltd Ramipril amine salts
GB0624082D0 (en) * 2006-12-01 2007-01-10 Selamine Ltd Ramipril metal salts
WO2008132756A1 (fr) * 2007-05-01 2008-11-06 Lupin Limited Compositions pharmaceutiques stables de ramipril

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE122228T1 (de) * 1991-07-01 1995-05-15 Gergely Gerhard Verfahren zur herstellung einer pharmazeutischen zubereitung mit wenigstens zwei verschiedenen wirkstoffen und verwendung einer solchen zubereitung.
ES2091654T3 (es) * 1993-04-15 1996-11-01 Gergely Gerhard Sistema efervescente que contiene un ingrediente activo farmaceutico sensible a alcalis y/o metales, y procedimiento para su produccion.
IE940292A1 (en) * 1994-04-06 1995-10-18 Elan Corp Plc Biodegradable microcapsules and method for their manufacture

Also Published As

Publication number Publication date
WO2002011709A2 (fr) 2002-02-14
WO2002011709A3 (fr) 2002-12-12
EP1309319B1 (fr) 2005-03-23
ATE291421T1 (de) 2005-04-15
DE50105710D1 (de) 2005-04-28
DE10038364A1 (de) 2002-05-02
EP1309319A2 (fr) 2003-05-14

Similar Documents

Publication Publication Date Title
CA2411754A1 (fr) Acide 4-¬(4-chloro-2-hydroxybenzoyl)amino|butanoique et compositions d'administration d'agents actifs
LV11984A (lv) Farmaceitiska kompozicija putojosa dzeriena pagatavosanai
WO2000078294A3 (fr) Forme galenique orale servant a administrer une combinaison fixe de tramadol et de diclofenac
EP2308479A3 (fr) Composés et compositions pour la distribution d'agents actifs
DK1007006T3 (da) Formulering af cefadroxilmonohydrattablet
WO2002015959A3 (fr) Composes et compositions permettant de distribuer des agents actifs
AU2001291731A1 (en) Pharmaceutical, effervescent formulation containing ramipril
AU2001278772A1 (en) Benzoic acid derivatives and drugs containing the same as the active ingredient
WO2003020200A3 (fr) Nouveau compose pharmaceutique et procedes de fabrication et d'utilisation de ce compose
EP1285660A4 (fr) Compositions d'apport complementaire de zinc destinees a une administration par voie orale
WO2003092655A3 (fr) Utilisation de melanges de principes actifs comme agents anti-acne
MXPA04003540A (es) Utilizacion de un copolimero para producir una forma galenica que contiene un peptido o proteina como agente activo.
NZ331083A (en) Pharmaceutical preparations of cilansetron stabilized against racemization
WO2004071156A3 (fr) Utilisation d'un acide comestible dans des formes posologiques pharmaceutiques solides a dispersion rapide
BE2016C017I2 (fr)
WO2003028624A3 (fr) Compositions de levothyroxine et procedes
WO2001022917A3 (fr) Compositions effervescentes comportant du nimesulide
PL350413A1 (en) Pharmaceutical effervescent formulation containing metamizol
WO2004014318A3 (fr) Compositions de levothyroxine et procedes
AU2001258859A1 (en) Pralmorelin-containing nasal drop preparations
WO2001091733A3 (fr) Combinaison de principes actifs contenant de la montireline et un compose a effet opioide
NZ521515A (en) Composition comprising paracetamol and niflumic acid
AU4137300A (en) Stable solid pharmaceutical compositions containing enalapril maleate
AU2003232535A1 (en) "soluble stable pharmaceutical composition for the administration of hiv protease inhibitors and a process for the preparation of concentrated pharmaceutical compositions for the administration of hiv protease inhibitors."
AU2001242819A1 (en) Pharmaceutical compositions containing as the active ingredient nitropyrimidine derivatives or salts thereof